BioNTech SE (BNTX)
103.40
-8.08
(-7.25%)
USD |
NASDAQ |
Nov 14, 16:00
102.20
-1.20
(-1.16%)
After-Hours: 20:00
BioNTech Revenue (Quarterly): 1.369B for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.369B |
| June 30, 2024 | 138.58M |
| March 31, 2024 | 203.77M |
| December 31, 2023 | 1.593B |
| September 30, 2023 | 974.79M |
| June 30, 2023 | 182.87M |
| March 31, 2023 | 1.372B |
| December 31, 2022 | 4.375B |
| September 30, 2022 | 3.487B |
| June 30, 2022 | 3.405B |
| March 31, 2022 | 7.153B |
| December 31, 2021 | 6.328B |
| September 30, 2021 | 7.177B |
| Date | Value |
|---|---|
| June 30, 2021 | 6.398B |
| March 31, 2021 | 2.468B |
| December 31, 2020 | 411.82M |
| September 30, 2020 | 78.93M |
| June 30, 2020 | 45.92M |
| March 31, 2020 | 30.57M |
| December 31, 2019 | 31.00M |
| September 30, 2019 | 31.87M |
| June 30, 2019 | 28.97M |
| March 31, 2019 | 29.71M |
| December 31, 2018 | 72.77M |
| September 30, 2018 | 23.72M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
30.57M
Minimum
Mar 2020
7.177B
Maximum
Sep 2021
2.361B
Average
1.370B
Median
Revenue (Quarterly) Benchmarks
| Edap TMS SA | 17.00M |
| Biodexa Pharmaceuticals PLC | -- |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |
| Moderna Inc | 1.855B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 217.87M |
| Total Expenses (Quarterly) | 1.357B |
| EPS Diluted (Quarterly) | 0.8908 |
| Enterprise Value | 8.336B |
| Gross Profit Margin (Quarterly) | 85.63% |
| Profit Margin (Quarterly) | 15.91% |
| Earnings Yield | -2.05% |
| Normalized Earnings Yield | -2.045 |